Approved awards support patient-centered comparative clinical effectiveness research (CER) on telehealth interventions, heart care and various health concerns WASHINGTON , Aug. 13, 2024 /PRNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling more than $165 million for new patient-centered comparative clinical effectiveness research (CER), as well as research to improve methods and strengthen the science of engagement in patient-centered CER. Among the 10 CER studies awarded, three will evaluate the effectiveness of telehealth interventions to treat Type 2 diabetes, chronic low back pain and opioid use disorder.
PCORI will fund two large, multiphase CER studies, expanding its growing portfolio of PCORI-funded research on care approaches for patients with heart conditions, including heart rhythm disorders. In one study, researchers will compare two commonly prescribed beta blockers in patients with heart failure and implantable cardioverter defibrillators (ICDs). In the second study, researchers will compare different methods for monitoring pacemakers and ICDs that use wireless remote monitoring.
"These latest PCORI-funded comparative clinical effectiveness research studies will generate evidence for various care approaches, including virtual delivery methods, when managing conditions such as diabetes, heart conditions and other health concerns affecting patients across the nation," said Nakela L. Cook , M.